Omalizumab is effective and available for treatment of patients with severe allergic asthma in Poland

Pol Arch Intern Med. 2017 Oct 31;127(10):715-717.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Anti-Allergic Agents / therapeutic use
  • Anti-Asthmatic Agents / therapeutic use
  • Asthma / drug therapy*
  • Child
  • Female
  • Humans
  • Male
  • Middle Aged
  • Omalizumab / therapeutic use*
  • Poland
  • Treatment Outcome
  • Young Adult

Substances

  • Anti-Allergic Agents
  • Anti-Asthmatic Agents
  • Omalizumab